Solutions’ customers have access one of the most extensive routine and specialty testing menus in the industry. In addition our technology partnerships and internal assay development programs have produced a large offering of novel biomarkers.
Since 2012 Q2
Solutions has developed more than 150 new biomarker assays.
Our Translational Science laboratories are strategically located in Atlanta, GA, San Juan Capistrano and Valencia, CA; Edinburgh, UK, and Singapore.
Each central lab is staffed by dedicated teams of scientists and fully equipped with state-of-the-art technologies and standardized instrumentation. You'll find the R&D support you need including expertise in fluid, tissue and cell-based assay development for biomarker testing as well as a range of methodologies to address the specific biomarker and assay development demands of your study.
about our end to end biomarker capabilities.
Our experts in biomarker discovery are providing a better understanding of therapeutic targets, molecular signaling, drug biology and patient response. Q2
Solutions has over 20 years of biomarker development, validation and deployment experience. Those insights add significant value as we develop new assays for your trials.
Learn more about our central labs capabilities including our companion diagnostic
and specimen management services